Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Iliadis, S. I., Koulouris P., Gingnell M., Sylvén S. M., Sundström-Poromaa I., Ekselius L., et al. (2015).  Personality and risk for postpartum depressive symptoms.. Arch Womens Ment Health. 18(3), 539-46.
Koutkias, V. G., Chouvarda I., Triantafyllidis A., Malousi A., Giaglis G. D., & Maglaveras N. (2010).  A personalized framework for medication treatment management in chronic care.. IEEE Trans Inf Technol Biomed. 14(2), 464-72.
Papadimitroulas, P., Erwin W. D., Iliadou V., Kostou T., Loudos G., & Kagadis G. C. (2018).  A personalized, Monte Carlo-based method for internal dosimetric evaluation of radiopharmaceuticals in children.. Med Phys.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzivras D., et al. (2019).  A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.. Ann N Y Acad Sci. 1452(1), 12-17.
Rammaert, B., Puyade M., Cornely O. A., Seidel D., Grossi P., Husain S., et al. (2019).  Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts. Transpl Infect Dis. 21(5), e13141.
Efthimiadis, G. K., Zegkos T., Meditskou S., & Hadjimiltiades S. (2014).  Perspectives on sudden death prevention in hypertrophic cardiomyopathy.. Cardiol Rev. 22(5), 210-6.
Triantafyllidis, A. K., Koutkias V. G., Chouvarda I., & Maglaveras N. (2013).  A pervasive health system integrating patient monitoring, status logging and social sharing.. IEEE J Biomed Health Inform. 17(1), 30-7.
Weiner, S. E., Tsatsos M. C., Cederbaum L. S., & Lode A. U. J. (2017).  Phantom vortices: hidden angular momentum in ultracold dilute Bose-Einstein condensates.. Sci Rep. 7, 40122.
Souliotis, K., Papageorgiou M., Politi A., & Athanasiadis A. (2016).  Pharmaceutical Pricing Policy in Greece: Toward a Different Path.. Front Public Health. 4, 185.
Fountoulakis, K. N. (2010).  Pharmaceutical treatment of acute bipolar depression.. F1000 Med Rep. 2,
Simitsopoulou, M., Chlichlia K., Kyrpitzi D., Walsh T. J., & Roilides E. (2018).  Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.. Antimicrob Agents Chemother. 62(8), 
Meletiadis, J., Al-Saigh R., Velegraki A., Walsh T. J., Roilides E., & Zerva L. (2012).  Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.. Antimicrob Agents Chemother. 56(1), 403-10.
Fountoulakis, K. N., Gazouli M., Kelsoe J., & Akiskal H. (2015).  The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder.. Eur Neuropsychopharmacol. 25(3), 335-42.
Vasilopoulos, Y., Sarri C., Zafiriou E., Patsatsi A., Stamatis C., Ntoumou E., et al. (2014).  A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population.. Pharmacogenomics J. 14(6), 523-5.
Karras, S. N., Rapti E., Koufakis T., Kyriazou A., Goulis D. G., & Kotsa K. (2017).  Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus.. Curr Clin Pharmacol. 12(4), 202-209.
Kyriakidou, A., Koufakis T., Goulis D. G., Vasilopoulos Y., Zebekakis P., & Kotsa K. (2021).  Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management.. Curr Pharm Des. 27(8), 1025-1034.
Filippatos, T. D., Athyros V. G., & Elisaf M. S. (2014).  The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].. Expert Opin Drug Metab Toxicol. 10(6), 787-812.
Kontou, P., Chatzika K., Pitsiou G., Stanopoulos I., Argyropoulou-Pataka P., & Kioumis I. (2011).  Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease.. Antimicrob Agents Chemother. 55(9), 4149-53.
Antachopoulos, C., Ilia S., Kadiltzoglou P., Baira E., Dokoumetzidis A., Gikas E., et al. (2018).  Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients.. Antimicrob Agents Chemother. 62(6), 
Kontou, P., Manika K., Chatzika K., Papaioannou M., Sionidou M., Pitsiou G., et al. (2013).  Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections.. Int J Antimicrob Agents. 42(3), 262-7.
Amaniti, A., Sardeli C., Fyntanidou V., Papakonstantinou P., Dalakakis I., Mylonas A., et al. (2019).  Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis.. Medicina (Kaunas). 55(12), 
Griebeler, M. L., Morey-Vargas O. L., Brito J. P., Tsapas A., Wang Z., Leon B. G. Carranza, et al. (2014).  Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.. Ann Intern Med. 161(9), 639-49.
Giannopoulos, A. A., Giannoglou G. D., & Chatzizisis Y. S. (2016).  Pharmacological approaches of refractory angina.. Pharmacol Ther. 163, 118-31.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Papademetriou, V., & Papadopoulos C. (2020).  Pharmacological management of diabetic nephropathy.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές